Citation Impact
Citing Papers
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
2006
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
2008
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Antiproliferative Effects of IFN- α Correlate with the Downregulation of Nuclear Factor- κ B in Human Burkitt Lymphoma Daudi Cells
2001
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
1999
Sarcoma and Skin Radiation Oncology
2006
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
2006
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma
1999
Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy
2000
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Molecular imaging in drug development
2008 Standout
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
2002
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
2002
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin
1993
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high‐risk sarcomas
2006
Structure and function of the blood–brain barrier
2009 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
2001
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma
2003
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
2002
A Feasibility, Toxicity, and Early Response Study of Etoposide, Ifosfamide, and Vincristine for the Treatment of Children with Rhabdomyosarcoma: A Report from the Intergroup Rhabdomyosarcoma Study (IRS) IV Pilot Study
1997
Overview of Sarcomas in the Adolescent and Young Adult Population
2005
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group
2008
Soft-Tissue Sarcomas in Adults
2005 Standout
HSP90 and the chaperoning of cancer
2005 Standout
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma
1991
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Childhood soft tissue sarcomas incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project
2006
Chemotherapy for Osteosarcoma without High-Dose Methotrexate: A 12-Year Follow-Up on 53 Patients
2007
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
2013 StandoutNobel
Limb salvage in musculoskeletal oncology
2003
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
2001
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Osteosarcoma of the limbs.Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation
1988
Neuroblastoma
2007 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
VPAC and PAC receptors: From ligands to function
2008
Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma
1992
Ethnic and racial differences in patients with Ewing sarcoma
2010
Prognostic significance of DNA di-tetraploidy in neuroblastoma
2001
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Autoreceptor Control of Peptide/Neurotransmitter Corelease from PDF Neurons Determines Allocation of Circadian Activity in Drosophila
2012 StandoutNobel
Survivors of Childhood Cancer: Coming of Age
2008
Auditory complications in childhood cancer survivors: A report from the childhood cancer survivor study
2011
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
1999
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Evaluation of HLA-DR Expression and T-Lymphocyte Infiltration in Osteosarcoma
1998
Common Musculoskeletal Tumors of Childhood and Adolescence
1999
Congenital alveolar rhabdomyosarcomam
2001
Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients
2001
Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors
1983
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
123I-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis
2010
Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.
1985
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study
2000
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
1995
Tumour karyotype may be important in the prognosis of human neuroblastoma
1986
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
A radioimmunologic technique to screen for antibodies to α-2 interferon
1984
Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.
1990
Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas
1985
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
1997
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
1997
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process
1985
Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy
2003
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)
1986
Prognostic factors in bone sarcomas
1997
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.
1988
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study
1995
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Diagnosis of multiple cancer types by shrunken centroids of gene expression
2002 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
2001 Standout
Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults
2003
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Amplification and expression of the N-myc gene in neuroblastoma
1987
Works of J. Treuner being referenced
Spindle Cell Rhabdomyosarcoma
1992
The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience
1990
[131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma
1989
Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas
1989
Vasoactive intestinal polypeptide (VIP) induces calcium mobilization in the human neuroblastoma cell line SK-N-SH
1990
Reduction of N-myc expression by antisense RNA is amplified by interferon: Possible involvement of the 2-5A system
1990
Ifosfamide‐induced nephrotoxicity in 593 sarcoma patients: A report from the Late Effects Surveillance System
2006
Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow‐up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, september 1986
1987
Tumor size and prognosis in aggressively treated osteosarcoma.
1996
Combined111In-pentetreotide scintigraphy and123I-mIBG scintigraphy in neuroblastoma provides prognostic information
2000
Clinical Experiences in the Treatment of Neuroblastoma with131I-Metaiodobenzylguanidine
1986
Die GPO cooperativen Ewing-Sarkom Studien CESS 81/86:
1988
Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: The CESS 86 experience
1999
Hearing function in soft tissue sarcoma patients after treatment with carboplatin: A report from the Late Effects Surveillance System
2004
Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
1997
Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon
1981 Nature
Expression analysis of multidrug resistance associated genes in neuroblastomas.
1999
High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma
1999
Intensive Kombinationschemotherapie und β-Interferon zur Behandlung von Kindern mit metastasiertem Neuroblastom: Studie GPO-NB 79/82
1984
Kooperative Osteosarkomstudie COSS-77: Ergebnisse nach über 4 Jahren
1982
Diagnosis of human childhood rhabdomyosarcoma by antibodies to desmin, the structural protein of muscle specific intermediate filaments
1982
Neuroblastomstudie NBL 79 der Gesellschaft für Pädiatrische Onkologie - Zwischenbericht nach 2 Jahren*
1982
Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
2001
Soft-Tissue Sarcomas in Childhood. A Study of 262 Cases Including 169 Cases of Rhabdomyosarcoma*
1985